Impact of antenatal selective serotonin reuptake inhibitor exposure on pregnancy outcomes in mice

被引:12
|
作者
Bauer, Samuel [1 ]
Monk, Catherine [2 ]
Ansorge, Mark [2 ]
Gyamfi, Cynthia [1 ]
Myers, Michael [2 ]
机构
[1] Columbia Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, New York, NY 10032 USA
[2] Columbia Univ, Div Dev Psychobiol, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA
关键词
birth outcomes; mouse model; pregnancy; preterm birth; selective serotonin reuptake inhibitor; RISK; BIRTH; DEPRESSION; FETAL; ANTIDEPRESSANTS; ESTRIOL; WOMEN;
D O I
10.1016/j.ajog.2010.05.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: This study investigates fluoxetine (FLX) exposure as an etiology for altered gestational length and adverse pregnancy outcomes. STUDY DESIGN: Two experiments were performed exposing mice to drinking water (H2O) or H2O + FLX. Primary outcomes included gestational length, litter size, and live birth rate. In experiment 1, time-mated dams were monitored for spontaneous birth, and gestational length was calculated. In experiment 2, dams were dissected on day 14 to verify litter size and qualities of embryo implantation. RESULTS: There was no difference in gestational length between H2O dams (480.7 +/- 13.2 hours) and H2O +/- FLX dams (483.5 +/- 10.1 hours), P = .70. Mean litter size was decreased in H2O + FLX dams (4.1 +/- 1.3/litter) compared to H2O dams (5.5 +/- 1.9/litter), P = .04. H2O + FLX dams were less likely to have live births (25.4%) compared to H2O dams (49.3%), P = .01. CONCLUSION: Antenatal FLX exposure did not statistically alter gestational length, but did affect litter size and spontaneous loss in mice. This warrants further investigation.
引用
收藏
页码:375.e1 / 375.e4
页数:4
相关论文
共 50 条
  • [1] Pregnancy outcomes in mice following antenatal selective serotonin reuptake inhibitor exposure
    Bauer, Samuel
    Monk, Catherine
    Ansorge, Mark
    Gyamfi, Cynthia
    Myers, Michael
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S52 - S53
  • [2] Impact of antenatal selective serotonin reuptake inhibitor exposure on length of gestation and pregnancy loss in mice
    Bauer, Samuel
    Monk, Catherine
    Ansorge, Mark
    Gyamfi, Cynthia
    Myers, Michael
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S256 - S256
  • [3] Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
    Lund, Najaaraq
    Pedersen, Lars H.
    Henriksen, Tine Brink
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (10): : 949 - 954
  • [4] Selective Serotonin Reuptake Inhibitor Exposure
    Fitzgerald, Kevin T.
    Bronstein, Alvin C.
    TOPICS IN COMPANION ANIMAL MEDICINE, 2013, 28 (01) : 13 - 17
  • [5] Selective Serotonin Reuptake Inhibitor Exposure in Pregnancy and Neonatal Adverse Events
    Dubnov-Raz, Gal
    Koren, Gideon
    Finkelstein, Yaron
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2010, 164 (04): : 394 - 394
  • [6] Adverse Outcomes Following Serotonin Reuptake Inhibitor Exposure During Pregnancy
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (02) : E199 - E200
  • [7] Selective Serotonin Reuptake Inhibitors Exposure During Pregnancy and Neonatal Outcomes
    Kawada, Tomoyuki
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (06) : 751 - 751
  • [8] The effect of antenatal selective serotonin reuptake inhibitor exposure on the corrected QT interval of neonates
    Lindsay-Sutherland, Marie
    JOURNAL OF PERINATOLOGY, 2021, 41 (06) : 1515 - 1518
  • [9] The effect of antenatal selective serotonin reuptake inhibitor exposure on the corrected QT interval of neonates
    Marie Lindsay-Sutherland
    Journal of Perinatology, 2021, 41 : 1515 - 1518
  • [10] Selective serotonin reuptake inhibitor antidepressants in pregnancy
    Ramio y Cristina Aguilera, Xenia
    MEDICINA CLINICA, 2007, 129 (05): : 194 - 196